| 000 | 014720000a22003130004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223032629.0 | ||
| 008 | 070326s2006 ua f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.18.M.Sc.2006.Sa.T | ||
| 100 | 0 | _aSamar Farid Fahmy | |
| 245 | 1 | 0 |
_aThrombosis in cancer patients Its prevention and treatment / _cSamar Farid Fahmy ; Supervised Nehad Tawfik , Mervat Mattar |
| 246 | 1 | 5 | _aالتجلط فى مرضى الاورام طرق الوقاية والعلاج |
| 260 |
_aCairo : _bSamar Farid Fahmy , _c2006 |
||
| 300 |
_a154P ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine | ||
| 520 | _aAlmost all types of cancer can be associated with the systemic activation of coagulation Avariety of hemostatic abnormalities have been reported in cancer patients these include shortening or prolongation of the prothrombin time and activated partial thromboplastin time , presence of activated coagulation factors , and elevation of fibrinogen and markers of thrombin generation , such as prothrombin | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aThrombosis in cancer | |
| 700 | 0 |
_aMervat Mattar , _eSupervisor |
|
| 700 | 0 |
_aNehad Tawfik , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAml _eCataloger |
||
| 905 |
_aEsam _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c78766 _d78766 |
||